Lesinelle

Drospirenone/Ethinylestradiol, the active ingredients in Lesinelle, are a combined oral contraceptive presented as a tablet for oral use. They work by suppressing ovulation and altering cervical mucus, providing reliable pregnancy prevention for women of reproductive age seeking hormonal contraception.

GNH USA supplies Lesinelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets European Union regulatory standards and is manufactured under GMP conditions to ensure consistent potency and safety. We provide comprehensive support for regulatory documentation and reliable logistics to our global partners.

Lesinelle, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy.

- Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential. - Hormonal contraception: used as part of a regimen to regulate menstrual cycles and provide cycle control. - Management of menstrual disorders: may be prescribed to treat dysmenorrhea or irregular bleeding when combined oral contraceptives are appropriate.

Adverse reactions may occur with any hormonal contraceptive. The following lists have been compiled from clinical data and post‑marketing experience.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like. - Breast tenderness: transient swelling or discomfort. - Mood changes: irritability or mild depressive symptoms. - Weight gain: modest increase in body weight. - Spotting: irregular breakthrough bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Hypertension: new‑onset or worsening high blood pressure. - Liver dysfunction: abnormal liver enzymes or cholestasis. - Hyperkalemia: elevated serum potassium levels. - Allergic reactions: rash, urticaria, or anaphylaxis. - Vision changes: rare ocular disturbances.

Before prescribing Lesinelle, clinicians should evaluate individual risk factors and contraindications.

- Cardiovascular risk assessment: avoid in patients with history of thromboembolic events. - Blood pressure monitoring: check regularly, especially in hypertensive patients. - Liver function evaluation: contraindicated in active liver disease. - Smoking status: discourage use in women over 35 who smoke. - Medication review: assess for interacting drugs that may affect efficacy. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Lesinelle may interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Antiepileptic enzymes inducers (e.g., carbamazepine, phenytoin): may reduce contraceptive efficacy. - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): can increase hormone levels and risk of side effects.

Moderate Interactions (Monitor Closely): - Antibiotics (e.g., rifampin): may modestly decrease effectiveness. - Herbal supplements (e.g., St John's wort): potential reduction in contraceptive effect. - Antifungal agents (e.g., fluconazole): may slightly increase hormone concentrations.